Drugs & medicalClass II

L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC…

cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay…

Read the official notice →
Date
2025-05-21
Country
United States
Brand
L'Oreal
Product
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC…
Classification
Class II
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More L'Oreal recalls

  1. 2026-02-06
  2. ITEU
    Cosmetics & chemicalschemical

    Hair dye (L'OREAL) · Excellence creme

    According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, harm the health of the unborn…

    EU Safety Gate · reported by ItalyL'OREALOfficial notice →
  3. 2025-05-21
  4. US
    Drugs & medicalClass II

    L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL.…

    Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

    FDA · DrugL'Oreal USANationwide in the USAOfficial notice →
  5. 2025-04-11
  6. ITEU
    Cosmetics & chemicalschemical

    Hair gel (L'OREAL) · 3 Force - Sculpte

    According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…

    EU Safety Gate · reported by ItalyL'OREALOfficial notice →
  7. ITEU
    Cosmetics & chemicalschemical

    Hairspray (L'OREAL) · Infinium

    According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…

    EU Safety Gate · reported by ItalyL'OREALOfficial notice →
  8. ITEU
    Cosmetics & chemicalschemical

    Hair cream (L'OREAL) · Steam pood

    According to the list of ingredients, the product contains 2-(4-tert- butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…

    EU Safety Gate · reported by ItalyL'OREALOfficial notice →
  9. 2025-01-31
  10. ITEU
    Cosmetics & chemicalschemical

    Hair gel (L'OREAL) · FIX & FORCE

    According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…

    EU Safety Gate · reported by ItalyL'OREALOfficial notice →
All 18 L'Oreal recalls →

Other drugs & medical recalls in the United States

  1. 2025-05-21
  2. US
    Drugs & medicalClass I

    Baxter Healthcare Corporation recalls Welch Allyn Life2000 Compressor, Product Codes: 1) BT-80-0004; 2) BT-80-0004A; 3) BT-80-0008; 4) BT-80-0008A; 5) RMS010093CP.

    A cybersecurity vulnerability was discovered through internal testing.

    FDA · DeviceBaxter Healthcare CorporationWorldwide distribution.Official notice →
  3. US
    Drugs & medicalClass I

    Vyaire Medical recalls Brand Name: AirLife Product Name: AirLife Infant Heated Wire Circuit Model/Catalog Number: AH165 Software Version: N/A Product…

    Adapters may disconnect during setup or while in use, potentially interrupting ventilation. Any disconnection can result in severe consequences for neonates, including hypoxia, hypercapnia, and organ failure.

    FDA · DeviceVyaire MedicalWorldwide distribution - US Nationwide and the countries of Germany, Poland,…Official notice →
  4. US
    Drugs & medicalClass II

    Empower Clinic Services, LLC dba Empower Pharmacy recalls Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by:…

    Lack of Assurance of Sterility

    FDA · DrugEmpower Clinic Services, LLC dba Empower PharmacyUSA NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL.…

    Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

    FDA · DrugL'Oreal USANationwide in the USAOfficial notice →
  6. 2025-05-14
  7. US
    Drugs & medicalClass II

    Philips Medical Systems Nederland B.V. recalls IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Model Number: 830089.

    An issue was identified with the software when using the Echo Module of ISCV, the issue may result in missing or incomplete information in the report.

    FDA · DevicePhilips Medical Systems Nederland B.V.Domestic: Nationwide Distribution International: Australia, Austria, Belgium,…Official notice →
  8. US
    Drugs & medicalClass II

    WANDERCRAFT SAS recalls Atalante X, Powered Exoskeleton. Atalante X is intended to perform ambulatory functions and mobility exercises, hands-free, in…

    Potential for exoskeleton to lose lateral balance and cause patient to fall.

    FDA · DeviceWANDERCRAFT SASDomestic: PA & NY.Official notice →
See all drugs & medical recalls →